SAVA Q1 2021 Earnings — Cassava Sciences, Inc. Revenue & Financial Results | Market Cap Arena

SAVACassava Sciences, Inc.

$115M

Q1 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$3M

Operating Income

-$4M

Net Income

-$4M

EPS (Diluted)

$-0.09

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$250,000

Balance Sheet

Total Assets

$284M

Total Liabilities

$3M

Stockholders' Equity

$281M

Cash & Equivalents

$282M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$3M	-$544,000	-364.9%
Operating Income	-$4M	-$1M	-189.1%
Net Income	-$4M	-$1M	-206.6%